NCT00345319
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
- Locations
-
- Danyang CDC Danyang, Jiangsu, China
Clinical trial condition
Rhabdoviridae Infections
Explore clinical trials studying Rhabdoviridae Infections. Study availability and eligibility vary by location and protocol.
79 public trials
2 recruiting studies
Rhabdoviridae Infections trial results
NCT00825305
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
- Locations
-
- Jizhou, Hebei, China
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
- Locations
-
- MDS Pharma Services , USA Lincoln, Nebraska, United States
NCT01107275
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
- Locations
-
- Phetchabun Province primary schools Phetchabun, Thailand
NCT00703521
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
- Locations
-
Not specified
NCT00694460
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +21 more
- Locations
-
- Tropical Medicine, Mahidol University Bangkok, Thailand
Active, Not Recruiting
Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang
NCT07624461
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
- Locations
-
- The Disease Prevention and Control Center of Nanyang Nanyang, Henan, China
Active, Not Recruiting
A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
NCT07275645
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
- Locations
-
- Qichun County Center for Disease Control and Prevention Huanggang, Hubei, China
- Yunyang District Center for Disease Control and Prevention Shiyan, Hubei, China
- Zhushan county Center for Disease control and Prevention Shiyan, Hubei, China
- Gucheng county Center for Disease control and Prevention Xiangyang, Hubei, China
Active, Not Recruiting
A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
NCT04270838
- Conditions
- Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
- Locations
-
- IHI Clinical Trial Facility Bagamoyo, Tanzania